Team:Alberta/Team
From 2009.igem.org
(Difference between revisions)
m |
|||
Line 44: | Line 44: | ||
<tr> | <tr> | ||
<td> | <td> | ||
- | <strong>Kalon Armstrong</strong> <br> | + | <div align="left"><strong>Kalon Armstrong</strong> <br> |
<em>Molecular Genetics</em> <br> | <em>Molecular Genetics</em> <br> | ||
<strong>Subteam: </strong>Plasmid construction | <strong>Subteam: </strong>Plasmid construction | ||
+ | </div> | ||
<td> | <td> | ||
</tr> | </tr> | ||
Line 68: | Line 69: | ||
<tr> | <tr> | ||
- | <td> | + | <td> |
+ | <div align="left"> | ||
<strong>Eric Bennett</strong><br> | <strong>Eric Bennett</strong><br> | ||
<em>Electrical Biomedical Engineering</em><br> | <em>Electrical Biomedical Engineering</em><br> | ||
<strong>Subteam: </strong>in vitro brick assembly development | <strong>Subteam: </strong>in vitro brick assembly development | ||
+ | </div> | ||
</td> | </td> | ||
</tr> | </tr> | ||
Line 95: | Line 98: | ||
<tr> | <tr> | ||
<td> | <td> | ||
+ | <div align="left"> | ||
<strong>Max Buchko</strong><br> | <strong>Max Buchko</strong><br> | ||
<em>Honors Biochemistry</em><br> | <em>Honors Biochemistry</em><br> | ||
<strong>Subteam: </strong>Cell reboot trigger development, Recombineering, Ethics, Business development | <strong>Subteam: </strong>Cell reboot trigger development, Recombineering, Ethics, Business development | ||
+ | </div> | ||
</td> | </td> | ||
</tr> | </tr> | ||
Line 122: | Line 127: | ||
<tr> | <tr> | ||
<td> | <td> | ||
+ | <div align="left"> | ||
<strong>Oscar Cortes</strong><br> | <strong>Oscar Cortes</strong><br> | ||
<em>Bsc. Specialization molecular genetics</em><br> | <em>Bsc. Specialization molecular genetics</em><br> | ||
<strong>Subteam: </strong>Plasmid construction | <strong>Subteam: </strong>Plasmid construction | ||
+ | </div> | ||
</td> | </td> | ||
</tr> | </tr> | ||
Line 147: | Line 154: | ||
<tr> | <tr> | ||
<td> | <td> | ||
+ | <div align="left"> | ||
<strong>Daniel Cotfas</strong><br> | <strong>Daniel Cotfas</strong><br> | ||
<em>Biological Sciences</em><br> | <em>Biological Sciences</em><br> | ||
<strong>Subteam: </strong>Website, Business, Ethics | <strong>Subteam: </strong>Website, Business, Ethics | ||
+ | </div> | ||
</td> | </td> | ||
</tr> | </tr> | ||
Line 173: | Line 182: | ||
<tr> | <tr> | ||
<td> | <td> | ||
+ | <div align="left"> | ||
<strong>Anh Dao</strong><br> | <strong>Anh Dao</strong><br> | ||
<em>Biological Sciences and Chemistry</em><br> | <em>Biological Sciences and Chemistry</em><br> | ||
<strong>Subteam: </strong>Project research literature resource management, Cell reboot trigger development, Recombineering | <strong>Subteam: </strong>Project research literature resource management, Cell reboot trigger development, Recombineering | ||
+ | </div> | ||
</td> | </td> | ||
</tr> | </tr> | ||
Line 197: | Line 208: | ||
<tr> | <tr> | ||
<td> | <td> | ||
+ | <div align="left"> | ||
<strong>Uchechukwu Davidson</strong><br> | <strong>Uchechukwu Davidson</strong><br> | ||
<em>Honors biochemistry</em><br> | <em>Honors biochemistry</em><br> | ||
<strong>Subteam: </strong>Cell reboot trigger development,ethics | <strong>Subteam: </strong>Cell reboot trigger development,ethics | ||
+ | </div> | ||
</td> | </td> | ||
</tr> | </tr> | ||
Line 223: | Line 236: | ||
<tr> | <tr> | ||
<td> | <td> | ||
+ | <div align="left"> | ||
<strong>Youness Elkhalidy</strong><br> | <strong>Youness Elkhalidy</strong><br> | ||
<em>Honors immunology and infection</em><br> | <em>Honors immunology and infection</em><br> | ||
<strong>Subteam: </strong>Cell reboot trigger development | <strong>Subteam: </strong>Cell reboot trigger development | ||
+ | </div> | ||
</td> | </td> | ||
</tr> | </tr> | ||
Line 247: | Line 262: | ||
<tr> | <tr> | ||
<td> | <td> | ||
+ | <div align="left"> | ||
<strong>Justin Fedor</strong><br> | <strong>Justin Fedor</strong><br> | ||
<em>Honours Biochemistry</em><br> | <em>Honours Biochemistry</em><br> | ||
<strong>Subteam: </strong>in vitro brick assembly development | <strong>Subteam: </strong>in vitro brick assembly development | ||
+ | </div> | ||
</td> | </td> | ||
</tr> | </tr> | ||
Line 267: | Line 284: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr> |
+ | <td> | ||
+ | <div align="left"> | ||
<strong>Jason Gardiner</strong> <br> | <strong>Jason Gardiner</strong> <br> | ||
<em>BSc. Specialization in Botany</em><br> | <em>BSc. Specialization in Botany</em><br> | ||
<strong>Subteam: </strong> Business development, Informatics | <strong>Subteam: </strong> Business development, Informatics | ||
- | </td></tr> | + | </div> |
+ | </td> | ||
+ | </tr> | ||
<tr><td> | <tr><td> | ||
Line 284: | Line 305: | ||
<tr><td> | <tr><td> | ||
+ | <div align="left"> | ||
<strong>Erin Garside</strong> <br> | <strong>Erin Garside</strong> <br> | ||
<em>Biological Sciences</em><br> | <em>Biological Sciences</em><br> | ||
<strong>Subteam: </strong>Literature management, plasmid construction and brick ensemble testing | <strong>Subteam: </strong>Literature management, plasmid construction and brick ensemble testing | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 300: | Line 322: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Boris Henriquez</strong><br> | <strong>Boris Henriquez</strong><br> | ||
<em>Biological Sciences</em><br> | <em>Biological Sciences</em><br> | ||
<strong>Subteam: </strong>Plasmid Construction | <strong>Subteam: </strong>Plasmid Construction | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 319: | Line 341: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Stephen Jahns</strong><br> | <strong>Stephen Jahns</strong><br> | ||
<em>Molecular Genetics</em><br> | <em>Molecular Genetics</em><br> | ||
<strong>Subteam: </strong>Cell reboot trigger development, Recombineering | <strong>Subteam: </strong>Cell reboot trigger development, Recombineering | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 337: | Line 359: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Denis Joly</strong><br> | <strong>Denis Joly</strong><br> | ||
<em>Major Biological Sciences, Minor Physical Sciences</em><br> | <em>Major Biological Sciences, Minor Physical Sciences</em><br> | ||
<strong>Subteam: </strong>N/A | <strong>Subteam: </strong>N/A | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 353: | Line 375: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Eric Leung</strong> <br> | <strong>Eric Leung</strong> <br> | ||
<em>Honors Pharmacology</em><br> | <em>Honors Pharmacology</em><br> | ||
<strong>Subteam: </strong> Essential gene/ Brick Amplification | <strong>Subteam: </strong> Essential gene/ Brick Amplification | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 372: | Line 394: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Qiwei Li</strong> <br> | <strong>Qiwei Li</strong> <br> | ||
<em>Biochemistry</em><br> | <em>Biochemistry</em><br> | ||
<strong>Subteam: </strong>Bioinformatics, Plasmid construction, Brick ensemble testing | <strong>Subteam: </strong>Bioinformatics, Plasmid construction, Brick ensemble testing | ||
- | </tr></td> | + | </div></tr></td> |
<tr><td> | <tr><td> | ||
Line 393: | Line 415: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>David Lloyd</strong><br> | <strong>David Lloyd</strong><br> | ||
<em> Biochemistry</em><br> | <em> Biochemistry</em><br> | ||
<strong>Subteam: </strong>Bioinformatics, Recombineering, Business Development. | <strong>Subteam: </strong>Bioinformatics, Recombineering, Business Development. | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 412: | Line 434: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Enoch Ng</strong><br> | <strong>Enoch Ng</strong><br> | ||
<em>Biological Sciences/Business</em><br> | <em>Biological Sciences/Business</em><br> | ||
<strong>Subteam: </strong>Informatics support, Business Development, Website management, Ethics | <strong>Subteam: </strong>Informatics support, Business Development, Website management, Ethics | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 428: | Line 450: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Emera Nguyen</strong><br> | <strong>Emera Nguyen</strong><br> | ||
<em>Biological Sciences/Economics</em><br> | <em>Biological Sciences/Economics</em><br> | ||
<strong>Subteam: </strong>Business Development, Website management | <strong>Subteam: </strong>Business Development, Website management | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 445: | Line 467: | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Chongya Niu</strong><br> | <strong>Chongya Niu</strong><br> | ||
<em>Honors Cell Biology</em><br> | <em>Honors Cell Biology</em><br> | ||
<strong>Subteam: </strong>Essential gene/brick amplification, Ethics. | <strong>Subteam: </strong>Essential gene/brick amplification, Ethics. | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 461: | Line 483: | ||
</td><tr> | </td><tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Mitch Paquette</strong><br> | <strong>Mitch Paquette</strong><br> | ||
<em>Major: Physical Science, Minor: Biological Science</em><br> | <em>Major: Physical Science, Minor: Biological Science</em><br> | ||
<strong>Subteam: </strong>Cell reboot trigger development, Recombineering | <strong>Subteam: </strong>Cell reboot trigger development, Recombineering | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 479: | Line 501: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Amber Paul</strong><br> | <strong>Amber Paul</strong><br> | ||
<em>BSc. Specialization Immunology and Infection</em><br> | <em>BSc. Specialization Immunology and Infection</em><br> | ||
<strong>Subteam: </strong>Bioinformatics, Essential gene/brick amplification, Website management, Ethics | <strong>Subteam: </strong>Bioinformatics, Essential gene/brick amplification, Website management, Ethics | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
<img src="http://igem.biochem.ualberta.ca/wiki/images/2/27/UofA_website_images_Amber_Paul_recrop.jpg" width="200" height="300" ALIGN="LEFT" hspace="20"> | <img src="http://igem.biochem.ualberta.ca/wiki/images/2/27/UofA_website_images_Amber_Paul_recrop.jpg" width="200" height="300" ALIGN="LEFT" hspace="20"> | ||
Line 494: | Line 516: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Julia Pon</strong><br> | <strong>Julia Pon</strong><br> | ||
<em>Honors Molecular Genetics</em><br> | <em>Honors Molecular Genetics</em><br> | ||
<strong>Subteam: </strong>Bioinformatics, Essential gene/brick amplification, Ethics. | <strong>Subteam: </strong>Bioinformatics, Essential gene/brick amplification, Ethics. | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 511: | Line 533: | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Alina Ponomarev</strong><br> | <strong>Alina Ponomarev</strong><br> | ||
<em>Biological Sciences/undeclared minor</em><br> | <em>Biological Sciences/undeclared minor</em><br> | ||
<strong>Subteam: </strong>Plasmid construction. | <strong>Subteam: </strong>Plasmid construction. | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 527: | Line 549: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Kelly Robinson</strong><br> | <strong>Kelly Robinson</strong><br> | ||
<em>Hon. Biochemistry</em><br> | <em>Hon. Biochemistry</em><br> | ||
<strong>Subteam: </strong>in vitro brick assembly development | <strong>Subteam: </strong>in vitro brick assembly development | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 545: | Line 567: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>James Rodway</strong><br> | <strong>James Rodway</strong><br> | ||
<em>Electrical Engineering</em><br> | <em>Electrical Engineering</em><br> | ||
<strong>Subteam: </strong>Informatics support,Bioinformatics | <strong>Subteam: </strong>Informatics support,Bioinformatics | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 565: | Line 587: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Andy Spencer</strong><br> | <strong>Andy Spencer</strong><br> | ||
<em>Honours Biochemistry</em><br> | <em>Honours Biochemistry</em><br> | ||
<strong>Subteam: </strong>Website management | <strong>Subteam: </strong>Website management | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 583: | Line 605: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Jonathan Tam</strong><br> | <strong>Jonathan Tam</strong><br> | ||
<em>Honors Cell Biotechnology</em><br> | <em>Honors Cell Biotechnology</em><br> | ||
<strong>Subteam: </strong>Informatics support. | <strong>Subteam: </strong>Informatics support. | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 599: | Line 621: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Jennifer Yau</strong><br> | <strong>Jennifer Yau</strong><br> | ||
<em>Honors Biochemistry</em><br> | <em>Honors Biochemistry</em><br> | ||
<strong>Subteam: </strong>Project research literature resource management, Ethics. | <strong>Subteam: </strong>Project research literature resource management, Ethics. | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> | ||
Line 615: | Line 637: | ||
</td></tr> | </td></tr> | ||
- | <tr><td> | + | <tr><td><div align="left"> |
<strong>Zach Wiltshire</strong> <br> | <strong>Zach Wiltshire</strong> <br> | ||
<em>Bsc. Specialization in cell biology</em><br> | <em>Bsc. Specialization in cell biology</em><br> | ||
<strong>Subteam: </strong>Business Development and Brick Ensemble Testing | <strong>Subteam: </strong>Business Development and Brick Ensemble Testing | ||
- | </td></tr> | + | </div></td></tr> |
<tr><td> | <tr><td> |
Revision as of 18:39, 27 July 2009
|
RE. coli
|